Review Article

Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease

Table 1

Relevant studies using transcriptomics in nephrology.

Reference Comparison Tissue/cellsSelected genes

[10]HD versus PD versus CKDPBMCUpregulated in HD
ATOX1, RELA, CSDE1, MIF, LTB4R, GSS, NFRKB
Upregulated in PD
HRH1, OLR1, CHST4, S100A8, CXCL12, GPX7
Upregulated in CKD
IL8RB, HDAC5, BCL6 P

[73] PRE-HD versus POST-HDBloodUpregulated POST-HD
TNF-A, IL-8, IL-18, IL-1RN, IL-4R, IL-10R, IFN-γR1, CX3CR1, CXCR4, CCR7, C3aR1
HD high CRP versus HD low CRPUpregulated in the low CRP group
IL-1RN, IL-4R, IL-10R, IFN-γR1, CX3CR1, CXCR4, CCR7

[74]HD versus HSMuscleUpregulated in HD
SP3, MEF2A, MAF, TCF8, SMARCA1, DICER1, SFRS11, HMGN3, UPF3A, EPM2A, SOS2, DEK, CLK1, CDC10, LAF4, BMI1, DDX17, MAPK6, ANAPC13, MYBPC1, C6orf111, KIAA0740, ART3, BIRC2, RABGGTB, OA48-18, CSE1L, SH3GLB1, MAP2K4, GLRX, PIP5K3, SLC35A1, VPS26, PXMP1, SRP54, SCP-2, SUCLA2, DMD, PRDX3, NDUFA5, NRIP1, XPO1, PSMC6, SEPP1, AXOT, LANCL1, SHOC2, FAM8A1, UBE1C, UBL3, PJA2, YME1L1, ELF2, OGT, IRS1, GATM, DLD, BZRP, PICALM, CAST, ANGPT1, ANK3, AKAP9, Rif1, CBX3, CBX1, ZNF146, MYH8, Tl132, MORC3, ZC3H11A, PURA, FLJ13110, GBAS, KTN1, SLC30A9, Tre
Downregulated in HD
PTK9L, IGFBP4, TRAP1, TAX1BP3, LGALS3BP, GNAI2, HBA1, HBB
PRE-HD versus POST-HDUpregulated in POST-HD
FST, GADD45A, GADD45B, IGFBP4, SAT, C-FOS, JUN-B, THBD, HES1, CCL2, CEBPD, BTG2, FOSL2, MYC, THBD, ZFP36, JE, NFIL3, SERPINB1, SCL39A14, NNMT, ARID5B
Downregulated in POST-HD
TOB1

[75]semisynthetic versus full-synthetic dialysis membranePBMCUpregulated in HD using semisynthetic membranes  
Immunity: ABCC5, ALOX12, CAMP, CCL2, CCR1, CD163, CLEC1B, CSF1R, CSF3R, CTSS, EPHX1, F2, FCGR1A, FGCR2B, GAB3, GBP1, GZMA, HLA-DQB1, HLA-DRB1, HLA-E, IRF7, ITGB1, KLRB1, LGALS9, LILRB3, LRRK2, LTB, MS4A2, PF4, PHCA, PPARA, PTPRC, RGS1, S100A8, SLA, TAP2, TGIF, TNFRSF8, XRCC6. Signal transduction: ABI3, ADRBK2, ARHGAP30, CCL2, CCR1, CENTA1, CHES1, CLEC1B, CSF1R, CSF3R, DOCK10, DTX4, ERBB3, FAS, FCGR1A, FCGR2B, FLJ23834, FPR1, GAB3, GABBR1, IFT140, ITGB1, LATS2, LILRA2, LILRB3, LIMS1, LRRK2, LTB, LTBP1, MAPK8, MS4A2, MYLK, NCF1, NRTN, P2RY13, PF4, PLCB2, PPARA, PTPN7, PTPRC, RAB9A, RASSF4, RGS1, RGS18, RGS6, SLA, SOCS3, TGIF, TNFRSF8, WSB2, WWTR1. Macrophage-mediated immunity: CD163, FCGR1A, FCGR2B, GAB3, GBP1, LTB, PF4, S100A8, TGIF. Natural killer cell-mediated immunity: CLEC1B, FCGR1A, FCGR2B, GZMA, KLRB1, LILRB3, LTB. T-cell-mediated immunity: CTSS, GAB3, GZMA, HLA-DQB1, HLA-DRB1, HLA-E, LTB, SLA, TNFRSF8. Cell motility: ABI3, CCR1, CSF1R, DOCK10, FPR1, ITGB1, LIMS1, LTBP1, PF4, S100A8, TUBB1. Cell surface receptor-mediated signal transduction: ADRBK2, CCL2, CCR1, CENTA1, CHES1, CSF1R, CSF3R, DTX4, ERBB3, FAS, FPR1, GAB3, GABBR1, IFT140, LIMS1, LTB, MS4A2, P2RY13, PF4, PLCB2, RGS1, RGS18, RGS6, SLA, TGIF, TNFRSF8. Apoptosis: FAS, GZMA, LGALS9, MYBL2, NAIP, NALP1, PDCD5, PF4, RASSF4, SOCS3, STK17B, TGIF. Intracellular protein traffic: CAMP, CD163, COMT, DOCK10, ERO1 L, IFT140, MX1, RAB9A, RASSF4, RIN1, RTN4, SSR2, STON2, STX5, TRAK2, TUBB1, YIPF5. Other metabolisms: AKR1C3, CA2, COMT, CRSP2, DIO2, GNPNAT1, MAP3K14, NEK2, PHCA, SLC27A3, SNAPC3. Cell cycle and cell cycle control: CCNB2, CYR61, EGFR, FOXF2, HTLF, JUN, KIF11, NBR2, TTK, TUBD1, UHRF1, WEE1

[76] PMN stimulated with shredded hollow fibres of CU or PS versus unstimulated PMNPMNUpregulated in PMN stimulated with shredded hollow fibres of CU or PS
AXUD1, FTH1, LIF, PTGS2, MGC12815, IL-1b, CCL3, CXCL1, SOCS3, PPIF, SPAG9, ACPP, DCT, GLA, GNS, PFKFB3, PLAU, USP36, SFRS3, DDX48, FLJ23231, PTD004, GNA13, HBEGF, DPYSL3, ARL8, GPR4, RASL11, DUSP2, EDN1, EDN3, EDNRB, JUN, FOS, EGR1, EGR2, DDIT3, EGR3, ELL2, NR4A3, TFAP2A, STAR, SEC31L1, ATP13A3, PHACTR1, TncRNA
Downregulated in PMN stimulated with shredded hollow fibres of CU or PS
FADD, FLI1, SOLH, YPEL3
PMN stimulated with E. Coli versus unstimulated PMNUpregulated in PMN stimulated with E. Coli
GADD45B, BIRC3, IER3, IER5, SGK, CDH24, ICAM1, CSF1, VEGF, NBS1, CCL18, CCL20, CCL3, CD48, CXCL1, CXCL2, CXCL3, IL1A, IL1B, IL1RN, LIF, MGC12815, NFIL3, PTGS2, SOCS3, TNF, TNFAIP6, EGR1, EGR2, ETS2, HIVEP1, ISL1, JUN, MAFF, MAFG, NFKB1, NFKBIA, NFKBIE, NFKBIZ, NR4A3, TFAP2A, TNFAIP3, XBP1, ZFHX1B, B4GALT5, DCT, FPGS, GCH1, GLA, GNPDA1, LOC285533, OAZIN, PLAU, PPIF, PPP1R15B, DDX48, FLJ23231, NMES1, SFMBT2, SNAPC3, TIFA, PHACTR1, ARL8, CALCA, CDC42EP3, DPYSL3, DUSP2, EDN1, EDN3, EHD1, GAB2, GPR4, MAPK6, NSMAF, SLC35B2, RHCG, SPAG9, VANGL1, VPS18, KCNJ2, AQP9
Downregulated in PMN stimulated with E. Coli
FADD, LAMB1, MEF2C, HNRPUL1, NDP52, YPEL3, DUSP6
PMN stimulated with E. Coli versus PMN stimulated with HD membraneUpregulated in PMN stimulated with E. Coli
CCL20, CXCL3, CCL3, IL1A, TNF, NFKBIA, NFKBIE, NFKBIZ, NFKB1, TNFAIP3, PLAU, IER5, ICAM3

[29]HD versus CKD III-IVPBMCUpregulated in HD  
AIF1, ATRN, BCL2, C1QBP, CADM1, CCL3, CD163, CD1D, CD300C, CD4, CD58, CD83, CD86, CEBPG, CLEC2B, CLEC4A, CLEC5A, CNIH, CTSC, CTSS, CXCL2, CXCL3, DNAJC8, EREG, FCAR, FTH1, FUS, GPR183, GPR65, GZMA, HLA-DMA, HLA-DMB, HLA-DPA1, HLA-DQB1, HLA-DRA, HLA-DRB1, ICOS, IFI30, IFI44, IGBP1, IL15, IL6ST, IL8, ILF2, ITGB1, ITGB2, KLRB1, KLRC1, KLRC3, KLRD1, KLRF1, LILRB2, LY86, LY96, NFIL3, PLA2G7, POMP, PRKRA, PTGER4, PTX3, RGS1, SAMHD1, SH2D1A, SIK1, SPN, TNFRSF25, TNFSF13, TNFSF8, VIPR1, XCL1, YTHDF2 
Downregulated in HD  
ACSL1, AIM2, ALOX15, ALOX5AP, ANXA11, APOL2, AQP9, ARHGDIB, ATP6V0A2, B2M, BCL2, C4A, CD24, CD27, CD2BP2, CD40, CD40LG, CD53, CD59, CD70, CD80, CD8B, CD97, CEACAM8, CNOT1, CNR2, DCLRE1C, DPP8, ELF4, FAIM3, FASLG, FCGR2A, FCGR2C, FCGR3A, FCGR3B, FYB, GBP1, GEM, GPR44, GPR68, GPSM3, GTF2I, GTPBP1, HLA-A, HLA-B, HLA-C, HLA-DOB, HLA-DPA1, HLA-DRB1, HLA-E, HLA-F, HLA-G, IFI16, IFI44, IFIT2, IFIT3, IFITM1, IFITM2, IFITM3, IGHA1, IGHD, IGHG1, IGKC, IGLL3P, IKBKG, IL16, IL18RAP, IL1A, IL1R1, IL1R2, IL1RAP, IL1RN, IL2RG, IL6R, IL7R, ILT4, IRF1, IRF2, IRF9, KIR2DL1, KLRG1, KRT1, LAT, LAT2, LILRA2, LILRB3, LSP1, LST1, LTF, LY9, LYST, MADCAM1, MAPRE2, MASP2, MBP, MNDA, MR1, MX2, MYD88, NCF2, NCF4, NCR2, NOTCH1, OASL, OTUB1, PGLYRP1, PLUNC, PSMB9, PSME1, PTAFR, PYHIN1, REG3A, S100A9, S1PR4, SECTM1, SEMA4D, SERPINA1, SIT1, SLC11A1, SLC4A1, ST6GAL1, TAPBP, TARP, TGFB2, TLR2, TLR6, TNFAIP6, TNFRSF13B, TNFRSF25, TNFRSF9, TNFSF10, TNFSF14, TOLLIP, TRAC, TRBC1, TRBC2, TREM1, TYROBP

[77]HD versus HSBloodUpregulated in HD  
MORN1, FGF18, ZNF205, ADARB1, GLTSCR2, SAP30L, ODF3B, SRCRB4D, TNPO2, MAPRE3, DUX4, RUNX3, PCGF5, GPR144, MAPK8IP2, ZFPL1, PLEKHG5, ELAVL3, FBXO44, UBE2J2, IL34, SLC25A37, SFTPC, PDLIM7, ARMC5, PLEKHN1, GNAS, EPN1, BCL2, CHCHD5, TFRC, RPS11, LMNA, CYP11B2, TMEFF2, GP1BB, TRIM8, VRTN 
Downregulated in HD  
ATP2A3, MESDC1, FBRSL1, RNF19B, ATPIF1, FKBP1A, ILF3, RBBP4, PEBP1, CTBP1, HINT1, KLHL24, KDM1B, MTA1, KCTD5, CCDC115, SLC23A2, ACAD8, RAB11FIP4, RNF19B, NONO, TNRC6A, NDUFB8, OGT, ATP5C1, MARCH5, PPP1R8, RALGAPB, IRF2, ESYT2, BHLHE40, RABGAP1, GABPB2, QKI, FLI1, RAB7A, PDCD4, BCL9L, RNF166, ACTL6A, S1PR1, GLUD1, CCDC88C, CSAD, ADSS, SRSF1, LOC93622, ACLY, PRF1, MAPK9, KLF7, PIK3IP1, TRIB2

[78]Mice with intraperitoneal injection of chlorhexidine gluconate versus controlParietal peritoneumUpregulated in parietal peritoneum treated with chlorhexidine gluconate  
PTGS2, COL8a1, Ddx3y, EIF2S3Y, ADAM12, Il6, CXCL1, MMP14, CCL7, ANKRD1, LRRC15, CCL2, G1p2, RUNX1, IRF7, CTHRC1, CYP7B1, PTN, COL5A2, FN1, CSPG2, THBS1, MS4A4C, LOX, GDF15, DNM3OS, RIAN, WISP1, SFRP1, COL3A1, STAT2, OASL2, TNC, NCAM1, ITGA5, TRIB3, GJA1, IFIT2, SERPINA3N, LOXL2, GLIPR2, OASL1, TIMP1 
Downregulated in parietal peritoneum treated with chlorhexidine gluconate  
IGH4

[79]PD/HD versus CKD III-IV/HSPBMCUpregulated in HD/PD  
B4GALT1, ANG, B3GNT2, CHPF2, CHST11, CHST2, CHSY1, CSGALNACT2, DSE, ERBB2IP, GNS, GUSB, HBEGF, HEXA, HEXB, HPSE, HS2ST1, RPL29, SGSH, SMC3, SOD1, TGFB1, VCAN, VEGFA, XYLT1 
Downregulated in HD/PD  
COL4A3, ACAN, AGRN, B3GNT1, B4GALT1, B4GALT3, B4GALT7, CHI3L1, COL7A1, CHPF, CHST1, B4GALT7, CHST15, CHST3, CHST8, COL13A1, COL18A1, COL1A2, COL5A3, COL9A2, DMD, DST, EXTL3, FBLN1, FMOD, GALNS, HABP2, HDGF, HEXA, IDS, LAMA2, LTBP2, NID2, LTBP4, MATN1, NAGLU, NDST1, NID2, PI3, PRSS1, SGCD, SNTB2, ST3GAL2, TGFB1, THBS4, TNFAIP6

[9]HD versus CKD II-III versus HSPBMCUpregulated in HD  
LSM3, TNFAIP3, JUNB, SFRS10, KLF4, MBD2, RPL36A, CLEC2B, CDV3, HMGN3, DNTTIP2, H3F3B, ZC3H15, TAF9, UQCRB, SNRPG, DBI, NDUFB1, UQCRH, COX6C, EEF1B2, NDUFA6, LOC732102, NDUFS5, HMGB1, DBI, TINP1, ATP5I, ATP5O, PFDN5, ATP5J, RPL23, RPS7, RPL34, TAX1BP1, PSMA6, SNRPE, HSP90AA1, ATG5, NDUFA1, AIF1, LSM7, NPM1, COX7C

[80]HD versus HSPBMCUpregulated in HD  
CASP1, NLRP3, NAIP5 
Downregulated in HD  
NLRP1, TXNIP, CARD8,